Davis A M, Devlin M, Griffin A M, Wunder J S, Bell R S
University Musculoskeletal Oncology Unit, Mount Sinai Hospital and University of Toronto, Canada.
Arch Phys Med Rehabil. 1999 Jun;80(6):615-8. doi: 10.1016/s0003-9993(99)90161-2.
To quantify the differences in physical disability and handicap experienced by patients with lower extremity sarcoma who required amputation for their primary tumor as compared with those treated by limb-sparing surgery.
Matched case-control study. Twelve patients with amputation were matched with 24 patients treated by limb-sparing surgery on the following variables: age, gender, length of follow-up, bone versus soft-tissue tumor, anatomic site, and treatment with adjuvant chemotherapy.
Patients who underwent above-knee amputation (AKA) or below-knee amputation (BKA) for primary soft-tissue or bone sarcoma, who had not developed local or systemic recurrence, and who had been followed up for at least 1 year since surgery.
The Toronto Extremity Salvage Score (TESS), a measure of physical disability; the Shortform-36 (SF-36), a generic health status measure; and the Reintegration to Normal Living (RNL), a measure of handicap.
Mean TESS score for the patients with amputations was 74.5 versus 85.1 for the limb-sparing patients. (p = .15). Only the physical function subscale of the SF-36 showed statistically significant differences, with means of 45 and 71.1 for the amputation versus limb-sparing groups, respectively (p = .03). The RNL for the amputation group was 84.4 versus 97 for the limb-sparing group (p = .05). Seven of the 12 patients with amputations experienced ongoing difficulty with the soft tissues overlying their stumps.
There was a trend toward increased disability for those in the amputation group versus those in the limb-sparing group, with the amputation group showing significantly higher levels of handicap. These data suggest that the differences in disability between amputation and limb-sparing patients are smaller than anticipated. The differences may be more notable in measuring handicap.
量化因原发性肿瘤而需要截肢的下肢肉瘤患者与接受保肢手术治疗的患者在身体残疾和残障方面的差异。
配对病例对照研究。12例截肢患者与24例接受保肢手术治疗的患者在以下变量上进行配对:年龄、性别、随访时间、骨肿瘤与软组织肿瘤、解剖部位以及辅助化疗治疗情况。
因原发性软组织或骨肉瘤接受膝上截肢(AKA)或膝下截肢(BKA)、未发生局部或全身复发且自手术以来已随访至少1年的患者。
多伦多肢体挽救评分(TESS),用于衡量身体残疾;简短健康调查问卷(SF-36),一种通用的健康状况衡量指标;以及重新融入正常生活(RNL),用于衡量残障。
截肢患者的平均TESS评分为74.5,而保肢患者为85.1。(p = 0.15)。只有SF-36的身体功能子量表显示出统计学上的显著差异,截肢组和保肢组的均值分别为45和71.1(p = 0.03)。截肢组的RNL为84.4,而保肢组为97(p = 0.05)。12例截肢患者中有7例其残肢上方的软组织持续存在问题。
截肢组患者与保肢组患者相比有残疾增加的趋势,截肢组的残障水平明显更高。这些数据表明,截肢患者和保肢患者在残疾方面的差异小于预期。在衡量残障方面,差异可能更显著。